Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families
- 10 May 2005
- journal article
- Published by Springer Nature in Human Genetics
- Vol. 117 (2-3) , 119-132
- https://doi.org/10.1007/s00439-005-1297-9
Abstract
The Quebec population contains about six-million French Canadians, descended from the French settlers who colonized “Nouvelle-France” between 1608 and 1765. Although the relative genetic contribution of each of these founders is highly variable, altogether they account for the major part of the contemporary French-Canadian gene pool. This study was designed to analyze the role of this founder effect in the introduction and diffusion of the BRCA1 recurrent R1443X mutant allele. A highly conserved haplotype, observed in 18 French-Canadian families and generated using 17 microsatellite markers surrounding the BRCA1 locus, supports the fact that the R1443X mutation is a founder mutation in the Quebec population. We also performed haplotyping analysis of R1443X carriers on 19 other families from seven different nationalities; although the same alleles are shared for three markers surrounding the BRCA1 gene, distinct haplotypes were obtained in four families, suggesting multiple origins for the R1443X mutation. Ascending genealogies of the 18 French Canadian families and of controls were reconstructed on an average depth of 10 generations. We identified the founder couple with the highest probability of having introduced the mutation in the population. Based on the descending genealogy of this couple, we detected the presence of geographical concentration in the diffusion pattern of the mutation. This study demonstrates how molecular genetics and demogenetic analyses can complement each other to provide findings that could have an impact on public health. Moreover, this approach is certainly not unique to breast cancer genetics and could be used to understand other complex traits.Keywords
This publication has 56 references indexed in Scilit:
- Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in FinlandEuropean Journal of Human Genetics, 2000
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerAmerican Journal of Human Genetics, 2000
- ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFNature Genetics, 2000
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testingEuropean Journal Of Cancer, 1997
- Frequencies of cystic fibrosis mutations in the Maine population: high proportion of unknown alleles in individuals of French-Canadian ancestryHuman Genetics, 1996
- A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Detection of polymorphisms in the estradiol 17β-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11–q21Human Molecular Genetics, 1993
- The Processing of Ambiguous Links in Computerized Family ReconstructionHistorical Methods: A Journal of Quantitative and Interdisciplinary History, 1986